Chronic Insomnia Market, Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight

November 12 22:17 2021
Chronic Insomnia Market, Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight
Chronic Insomnia Market

Insomnia is the most common sleep disorder with huge socio-economic costs. According to the third edition of the International Classification of Sleep Disorders (ICSD-3), it is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. However, Chronic Insomnia is more complex, accompanied by daytime impairment of cognition, mood, or performance.


The Chronic Insomnia Market report offers a comprehensive analysis of the disease overview, its causes, signs/ symptoms, and diagnosis modalities. The report highlights the available treatment, pipeline therapies, and factors changing the Chronic Insomnia market landscape during the study period 2018-30 in the 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan).

The Chronic Insomnia market size insights report is designed to identify and grab true opportunities in the Chronic Insomnia market landscape, help clients form collaborations and ink deals that give them a competitive advantage and plan strategic moves to yield maximum returns.


Some key facts of the Chronic Insomnia market report: 

  • The total diagnosed Chronic Insomnia prevalent population in the 7MM countries was estimated to be 5,585,128 cases in 2020.
  • The US reported the highest Chronic Insomnia patient pool, more than 2,500,000 in 2020.
  • The US accounted for the maximum share of the Chronic Insomnia market size, approximately 66.42% of the overall market size of Chronic Insomnia in 2020.
  • Key pharmaceutical companies energetically working in the Chronic Insomnia market are Idorsia Pharmaceuticals, Janssen Research & Development/Minerva Neurosciences, and Sequential Medicine, among others.
  • Key pipeline therapies set to place their foot in the market during the forecast period 2021-30 include Daridorexant, Seltorexant, SM-1, and several others.




Interested in learning more? Request for Sample @ Chronic Insomnia Market Analysis and Forecast


Various studies worldwide have shown the prevalence of insomnia in 10–30% of the population, some even as high as 50–60%. As per DelveInsight’s Chronic Insomnia epidemiological analysis, Chronic Insomnia is slightly more prevalent among females than males.


The Chronic Insomnia market report offers historical and forecasted epidemiological analysis during the study period 2018-30 in the 7MM segmented into:

  • Chronic Insomnia Prevalent Cases
  • Chronic Insomnia Diagnosed Prevalent Cases
  • Gender-specific Chronic Insomnia Cases
  • Age-specific Chronic Insomnia Cases


For more insights, visit Chronic Insomnia Epidemiological Analysis and Forecast


Chronic Insomnia Market

The primary goal of the Chronic Insomnia market is to improve sleeping habits and alleviate symptoms such as distress and dysfunction. It can be managed with the help of psychological therapy, pharmacologic therapy, or a combination of both.

Psychological therapy options present in the Chronic Insomnia market include cognitive behavioral therapy for insomnia (CBT-I), multicomponent behavioral therapy or brief behavioral therapy (BBT) for insomnia, and other interventions, such as stimulus control, relaxation strategies, and sleep restriction.

Benzodiazepines are frequently prescribed to treat insomnia. Five benzodiazepines (estazolam, flurazepam, quazepam, temazepam, and triazolam) are in market as the FDA-approved medications for insomnia management. Non-benzodiazepine hypnotics include zopiclone, zolpidem, and zaleplon. Orexin receptor antagonists, including Dayvigo and Belsomra, recently gained popularity in the Chronic Insomnia market therapy.



Chronic Insomnia Pipeline Therapies

  • Daridorexant: Idorsia Pharmaceuticals
  • Seltorexant: Janssen Pharmaceuticals
  • SM-1: Sequential Medicine
  • And Many More


Scope of the Report 

Coverage: 7MM (the US, EU5, and Japan)

Study Period: 2018-30

Key Companies: Idorsia Pharmaceuticals, Janssen Pharmaceuticals, Sequential Medicine

Key Chronic Insomnia Pipeline Therapies: Daridorexant, Seltorexant, SM-1

Chronic Insomnia Market Segmentation: By Geography, By Chronic Insomnia Therapies

Analysis: Comparative and conjoint analysis of Chronic Insomnia emerging therapies

Tools used: SWOT analysis, Conjoint Analysis, Porter’s Five Forces, PESTLE analysis, BCG Matrix analysis methods.

Case Studies

KOL’s Views

Analyst’s Views


Table of Contents


Key Insights


Report Introduction


Chronic Insomnia Market Overview at a Glance


Executive Summary of Chronic Insomnia


Chronic Insomnia Epidemiology and Patient Population


Chronic Insomnia Patient Journey


Organizations contributing to Chronic Insomnia


Treatment Algorithm, Current Treatment, and Medical Practices


Key Endpoints in Chronic Insomnia Clinical Trials


Chronic Insomnia Marketed Therapies


Chronic Insomnia Emerging Therapies


Other Chronic Insomnia Promising Therapies


Chronic Insomnia: 7 Major Market Analysis


Access and Reimbursement Overview of Chronic Insomnia


KOL Reviews


Case Reports


Chronic Insomnia Market Drivers


Chronic Insomnia Market Barriers


Chronic Insomnia Market Access


SWOT Analysis




DelveInsight Capabilities


About DelveInsight

DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.


About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Know more about our competitive intelligence services.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States